Biotechnology Market Size to Surpass USD 9.06 Trillion by…

According to Nova One Advisor, the global biotechnology market size is calculated at USD 2.79 trillion in 2026 and is expected to be worth around USD 9.06 trillion by 2035, growing at a compound annual growth rate (CAGR) of 13.97% over the forecast period 202…

The global biotechnology market size is calculated at USD 2.45 trillion in 2025, grew to USD 2.79 trillion in 2026, and is projected to reach around USD 9.06 trillion by 2035. The market is projected to expand at a CAGR of 13.97% between 2026 and 2035. Biotechnology is technology based on biology, which harnesses cellular and biomolecular procedures to develop technologies and products that support and enhance lives and the health of the planet.

Applications the biological processes of microorganisms for more than 6,000 years to make valuable food products, like bread and cheese, and to preserve dairy products. Biotechnology manufacturing provides a variety of advantages and solutions to significant challenges. Biotechnological processes create healthier, stronger, and more-sustainable food products, which increase nutrition and combat food insecurity.

It helps to manage diseases in children before they are born by altering their genomes. Designing biotechnological medicine to increase the health and longevity of patients, such as animals and plants, and cutting costs of farm supplies such as pesticides, while increasing crop yields and profits. Biotechnology products are more costly than traditional products and have the potential to increase pricing structures in different sectors.

Also, bio-based plants need more nutrients from the soil and produce more crops. This drains soil of fertile nutrients, overruns farmland, and requires the use of ecologically harmful fertilizers to make up for the nutrient loss, which limits the growth of the market. The U.S. biotechnology market size was valued at USD 0.85 trillion in 2025 and is anticipated to reach around USD 3.23 trillion by 2035, growing at a CAGR of 14.28% from 2026 to 2035.

North America is expected to generate the highest demand during the forecast period in the biotechnology market, as the aging population is more susceptible to developing ailments like heart disorders, stroke, diabetes, cancer, arthritis, hypertension, and other chronic diseases, which drive the biotechnology market. Increasing spending in biotechnology, such as in 2024, the five largest U.S. technology companies invested $227 billion in R&D, exceeding the federal government’s non-defense R&D expenses, which drives the growth of the market.

The Asia Pacific region is the fastest-growing in the biotechnology market, as Asia-Pacific’s emerging leadership in biotechnological services and Singapore’s strategic role in biotech are revolutionizing the future of medicine. This region has the most ground-breaking biotech companies because of Singapore’s ready infrastructure, robust IP protection, and constant guidelines, attracting biotech innovation in the region from precision medicine to cell therapy.

The Korea Drug Development Fund (KDDF) plans to help more than 1,200 novel drug development projects by 2030, backed by 2.17 trillion won ($1.5 billion) in government funding over the 10-year national program period, which drives the market growth. The rising demand for high-quality genetic therapies to treat a wide range of cancers along with rapid investment by biotech companies for opening up new research and development centers has boosted the market expansion.

Moreover, rise in number of biotech startups coupled with technological advancements in the biopharma sector is playing a vital role in shaping the industry in a positive manner. The increasing sales of hybrid fruits and hybrid vegetables coupled with rapid investment by market players for opening up biotech research centers has driven the market growth. Also, numerous government initiatives aimed at developing the healthcare sector is contributing to the industry in a positive direction.

Europe is a significant contributor of the biotechnology industry. The rapid expansion of the nanobiotechnology sector in several countries including Germany, Italy, France, UK, Denmark and some others has driven the market growth. Additionally, numerous government initiatives aimed at developing the developing the biotechnology sector is playing a vital role in shaping the industrial landscape. Moreover, the presence of various market players such as Roche, Novartis, Biontech and some others is expected to propel the growth of the biotechnology market in this region.

The growing demand for DNA-based therapeutics to treat chronic diseases coupled with rapid investment by the healthcare companies for developing a wide range of cell therapies has boosted the market expansion. Moreover, rapid investment by government for developing the genetic engineering sector is playing a prominent role in shaping the industrial landscape. Latin America has played a prominent role in the biotechnology market.

The growing demand for cell-based assays from the food and beverage sector in numerous nations such as Brazil, Argentina, Venezuela and some others has boosted the market expansion. Also, rapid investment by government for enhancing the bioinformatics sector is contributing to the industry in a positive manner. Moreover, the presence of numerous market players such as Biocure, Biofábrica Siglo, Bionovis and some others is expected to drive the growth of the biotechnology market in this region.

The rapid expansion of the tissue engineering sector coupled with technological advancements in the pharma industry has driven the market growth. Additionally, the growing demand for cell-based assays from the food and agriculture sector is contributing to the industry in a positive direction. Middle East and Africa held a notable share of the industry. The rising demand for RNA therapeutics for treating cancer in numerous countries including UAE, Saudi Arabia, Qatar, South Africa and some others has driven the market growth.

Also, technological advancements in the genetic engineering sector coupled with increasing adoption of hybrid vegetables in developed nations is playing a prominent role in shaping the industrial landscape. Moreover, the presence of several biotechnology companies including G42 Healthcare, NewBridge Pharmaceuticals, Julphar and some others is expected to boost the growth of the biotechnology market in this region.

The growing demand for high-quality hybrid vegetables coupled with technological advancements in the biotechnology sector has fostered the industrial expansion. Moreover, rapid investment by government for strengthening the pharmaceutical industry is playing a prominent role in shaping the industrial landscape. Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/6732 For more information, visit the Nova One Advisor website or email the team at  sales@novaoneadvisor.com | Call us: +1 804 420 9370  The DNA sequencing segment accounted for the dominating share of the market in 2025, as it needs less protein purification service.

DNA sequencing offers the means to know how nucleotide bases are arranged in a piece of DNA. Various technologies have been established for this process. DNA sequencing is used for genetic testing for paternity and other family relationships. It supports identifying crime suspects and victims involved in catastrophes. DNA sequencing has allowed physician to detect specific genetic mutations in patients, which support in the diagnosis and management of diseases.

Whereas the nanobiotechnology segment is predicted to register rapid expansion in the forecasting period, as nanobiotechnology in medicine is in drug distribution, it offers many advantages, such as an efficient drug delivery system is supposed to increase bioavailability and encapsulate the drug to remove adverse effects. Nanobiotechnology has found uses in tissue engineering and reconstruction. This technology, integrated with biomaterials in the generation of scaffolds for tissue reconstruction which used in the regulation of cell behaviour.

In 2025, the health biotechnology segment captured the biggest share of the biotechnology market, as biotechnology has transformed healthcare research, drug advancement, and treatment in fields such as precision medicine, cancer therapy, and vaccine advancement. It offers benefits such as developing personalized medicine, manufacturing advanced vaccines and targeted therapies, enhancing early disease diagnosis via genetic testing, allowing gene therapies for inherited disorders, and making essential medicines.

Although the industrial processing segment will expand fastest during 2026-2035, as industrial biotech processes are vigorous, advanced, and inherently cleaner than outdated manufacturing technology. Industrial biotechnology increases productivity while using limited and less power. It cuts emissions, including greenhouse gases, and lowers the use of fossil fuels. Industrial biotechnology increases productivity.

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has segmented the biotechnology market. Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/6732 Nova One Advisor is a global leader in market intelligence and strategic consulting, committed to delivering deep, data-driven insights that power innovation and transformation across industries.

With a sharp focus on the evolving landscape of life sciences, we specialize in navigating the complexities of cell and gene therapy, drug development, and the oncology market, enabling our clients to lead in some of the most revolutionary and high-impact areas of healthcare.  Our expertise spans the entire biotech and pharmaceutical value chain, empowering startups, global enterprises, investors, and research institutions that are pioneering the next generation of therapies in regenerative medicine, oncology, and precision medicine.